People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Other Technology, Healthtech, Mobility / Logistics, Pharma, Other Health Care, Investment Vehicle
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| hc1.com Inc. | — | Other Technology | Series A | $29.0M | $33.4M | 2015 |
| Deep Lens, Inc. | — | Other Technology | Series A | $16.8M | $378.8M | 2018 |
| Healthplan Data Solutions, Inc. | — | Healthtech | Series A | $16.7M | $56.1M | 2025 |
| Vantage Point Logistics, Inc. | — | Mobility / Logistics | Series A | $11.1M | $129.9M | 2015 |
| Monitored Therapeutics, Inc. | — | Pharma | Series A | $8.5M | $82.3M | 2021 |
| Prescribe FIT, Inc. | — | Other Health Care | Seed | $7.1M | $382K | 2023 |
| Tamarind Hill Fund, LLC | — | Investment Vehicle | Series A | $6.9M | $104.8M | 2017 |
| ClaimInformatics, Inc. | — | Other | Seed | $3.8M | $6.2M | 2022 |
| Healthy Roster, Inc. | — | Healthtech | Seed | $3.5M | $31.9M | 2021 |
| Tamarind II Pre-Fund SPV, LLC | — | Investment Vehicle | Seed | $1.1M | $20.4M | 2020 |
| MBA Focus, LLC | — | Other | Pre-Seed | $200K | $4.6M | 2012 |
Mark Shary at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Shary on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Benjamin Trumbull | 2 | 2 |
| Mark A. Shary | 2 | 2 |
| JACK GAINER | 2 | 2 |
| Michael Taylor | 1 | 7 |
| Ryan Helon | 1 | 5 |
| Mark D Shary | 1 | 4 |
| Tim Chapman | 1 | 4 |
| Theodore Capossela | 1 | 4 |
| Tim Kopp | 1 | 4 |
| John Baker | 1 | 4 |
| CHRIS BROWN | 1 | 3 |
| Bradley A. Bostic | 1 | 3 |
| James Grote | 1 | 3 |
| Weston Gaddy | 1 | 3 |
| Simon Arkell | 1 | 3 |
| John Mills | 1 | 3 |
| Shawn Price | 1 | 3 |
| Peter Davies | 1 | 3 |
| Michael Swanson | 1 | 2 |
| Steve Allen | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.